Impact of metformin in cardiometabolic risk factors in polycystic ovary syndrome: role of race/ethnicity

被引：0
|
作者：
Chatakondi, R. N. [1 ]
Salau, F. [1 ]
Pruett, J. [2 ]
Romero, D. G. [2 ]
Cardozo, L. Yanes [2 ]
机构：
[1] Univ Mississippi, Med Ctr, Greenville, MS USA
[2] Univ Mississippi, Med Ctr, Jackson, MS USA
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2023年 / 365卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
636
引用
收藏
页码：S347 / S348
页数：2
相关论文
共 50 条
  • [31] Metformin and polycystic ovary syndrome
    De Geyter, Christian
    Emch, Fabienne
    Ahler, Astrid
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2018, 16 (03): : 191 - 194
  • [32] Metformin and the polycystic ovary syndrome
    Nestler, JE
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (03): : 1430 - 1430
  • [33] Metformin in polycystic ovary syndrome
    Mascitelli, Luca
    Pezzetta, Francesca
    Goldstein, Mark R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (17): : 1867 - 1868
  • [34] Metformin in polycystic ovary syndrome
    Diamanti-Kandarakis, Evanthia
    Economou, Frangiskos
    Palimeri, Sotiria
    Christakou, Charikleia
    WOMEN'S HEALTH AND DISEASE, 2010, 1205 : 192 - 198
  • [35] Suboptimal dietary intake is associated with cardiometabolic risk factors in women with polycystic ovary syndrome
    Hart, Kathryn
    Barr, Suzanne
    Reeves, Sue
    Sharp, Kay
    Jeanes, Yvonne
    NUTRITION & DIETETICS, 2016, 73 (02) : 177 - 183
  • [36] Ethnicity in polycystic ovary syndrome
    Shah, D.
    Rasool, S.
    CLIMACTERIC, 2023, 26 (01) : 15 - 20
  • [37] Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race/Ethnicity
    Wolf, Wendy M.
    Wattick, Rachel A.
    Kinkade, Olivia N.
    Olfert, Melissa D.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (11)
  • [38] Polycystic ovary syndrome: is the cardiometabolic risk increased after menopause?
    Alur-Gupta, Snigdha
    Dokras, Anuja
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (03): : 331 - 333
  • [39] Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies
    Jacewicz-Swiecka, Malgorzata
    Kowalska, Irina
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34 (08)
  • [40] The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome
    Sahin, Yilmaz
    Unluhizarci, Kursad
    Yilmazsoy, Ayse
    Yikilmaz, Ali
    Aygen, Ercan
    Kelestimur, Fahrettin
    CLINICAL ENDOCRINOLOGY, 2007, 67 (06) : 904 - 908
12345